Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report

Abstract

Summary

Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Krka, d. d., Novo Mesto (Krka or 'the company') is a provider of prescription pharmaceuticals, non-prescription products, and animal health products. Its products are used for the treatment of cardiovascular diseases, diseases of the alimentary tract and metabolism, analgesics, disinfectants, and Cold and Cough. The company is also involved in the health resort business and provides tourist services. The company markets products under various brands such as atoris, roswera, ampril, lorista, septolete, pikovit, bilobil, flebaven, fypryst, enroxil amatib, otoxolan and flimabend brands, among others. Krka primarily operates in Europe, the Middle East, Africa, and the Americas. The company is headquartered in Novo Mesto, Slovenia.

Scope

- Detailed information on Krka, d. d., Novo mesto required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Krka, d. d., Novo mesto in the form of a SWOT analysis
- An in-depth view of the business model of Krka, d. d., Novo mesto including a breakdown and examination of key business segments
- Intelligence on Krka, d. d., Novo mesto's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Krka, d. d., Novo mesto, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Krka, d. d., Novo mesto and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Krka, d. d., Novo mesto as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Krka, d. d., Novo mesto's business structure, strategy and prospects.

Content

Table of Contents

Company Snapshot
Krka, d. d., Novo mesto: Company Overview
Krka, d. d., Novo mesto: Overview and Key Facts
Krka, d. d., Novo mesto: Overview
Krka, d. d., Novo mesto: Key Facts
Krka, d. d., Novo mesto: Key Employees
Krka, d. d., Novo mesto: Key Employee Biographies
Krka, d. d., Novo mesto: Major Products and Services
Krka, d. d., Novo mesto: Company History
Krka, d. d., Novo mesto: Management Statement
Krka, d. d., Novo mesto: Locations and Subsidiaries
Krka, d. d., Novo mesto: Key Competitors
Krka, d. d., Novo mesto: Company Analysis
Krka, d. d., Novo mesto: Business Description
Krka, d. d., Novo mesto: SWOT Analysis
Krka, d. d., Novo mesto: SWOT Overview
Krka, d. d., Novo mesto: Strengths
Krka, d. d., Novo mesto: Weaknesses
Krka, d. d., Novo mesto: Opportunities
Krka, d. d., Novo mesto: Threats
Krka, d. d., Novo mesto: Recent Developments
Krka, d. d., Novo mesto: News and Events Summary
Krka, d. d., Novo mesto: Corporate Governance
Krka, d. d., Novo mesto: Financial Performance
Krka, d. d., Novo mesto: Research & Development
Krka, d. d., Novo mesto: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Krka, d. d., Novo mesto: Key Facts
Table 2: Krka, d. d., Novo mesto: Key Employees
Table 3: Krka, d. d., Novo mesto: Company History
Table 4: Krka, d. d., Novo mesto: Locations and Subsidiaries
Table 5: Krka, d. d., Novo mesto: Key Competitors
Table 6: Krka, d. d., Novo mesto: News and Events Summary
Table 7: Krka, d. d., Novo mesto: Corporate Governance
Table 8: Krka, d. d., Novo mesto: Financial Performance
Table 9: Krka, d. d., Novo mesto: Research & Development
Table 10: Krka, d. d., Novo mesto: Strategy and Operations